Publication | Closed Access
EMPAGLIFLOZIN INDUCES A MYOCARDIAL METABOLIC SHIFT FROM GLUCOSE CONSUMPTION TO KETONE METABOLISM THAT MITIGATES ADVERSE CARDIAC REMODELING AND IMPROVES MYOCARDIAL CONTRACTILITY
32
Citations
0
References
2018
Year
Cardiovascular ToxicityMetabolic SyndromeCardiomyopathyCardiac MuscleCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyMetabolismPharmacologyCardiologyHealth Sciences
No additional data available for this publication yet. Check back later!